Intellectual Property, Competition and Access in Europe: The flawed incentives of the current model 18 November 2010 Sophie Bloemen Health Action International (HAI) Europe

First Page		Document Content
Date: 2011-07-21 04:52:12 Pharmacology Intellectual property law Pharmacy Generic drug Patent Innovation Generic Pharmaceutical Price Decay Health Impact Fund Pharmaceutical sciences Pharmaceuticals policy Pharmaceutical industry		Intellectual Property, Competition and Access in Europe: The flawed incentives of the current model 18 November 2010 Sophie Bloemen Health Action International (HAI) Europe Add to Reading List Source URL: haieurope.org Download Document from Source Website File Size: 441,93 KB Share Document on Facebook

	PDF Document DocID: 1xvUb - View Document
	PDF Document DocID: 1xc8R - View Document
	Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME DocID: 1vqsj - View Document
	Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia DocID: 1vlJU - View Document
	Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology DocID: 1vk1K - View Document